Intraocular non-Hodgkin's lymphoma - A case series of ten patients;Das intraokulare non-Hodgkin-lymphom und seine therapie - Eine fallserie mit 10 patienten

Klinische Monatsblatter fur Augenheilkunde

Volumn 221, Issue 4, 2004, Pages 266-272

  Siepmann, Kirsten ^a   Rohrbach, I M ^a   Duncker, G ^b   Zierhut, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Intraocular lymphoma; Masquerade syndrome; PCNSL; Uveitis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; LOMUSTINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN LYMPHOMA; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAOCULAR LYMPHOMA; MALE; MENINX; METASTASIS; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; SEX RATIO; SPINAL CORD TUMOR; UVEITIS; VITREOUS BIOPSY;

AGED; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EYE NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TREATMENT OUTCOME; UVEITIS;

EID: 3142665498     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812999     Document Type: Article

References (42)

1. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859-863
2. Akpek EK, Ahmed I, Hochberg FH et al. Intraocular-central nervous system lymphoma. Ophthalmology 1999; 106: 1805-1810
3. Akpek EK, Maca SM, Christen WG et al. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology 1998; 106: 2291-2295
4. Balmaceda C, Gaynor JJ, Sun H et al. Leptomeningeal tumor in primary CNS lymphoma: recognition, significance and implications. Ann Neurol 1995; 38: 202-206
5. Blay JY, Burdin N, Rousset F et al. Serum Interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993; 82: 2169-2174
6. Blay JY, Conroy T, Chevreau C et al. High dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998; 16: 864-871
7. Chamberlain MC, Levin VA. Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neuro-Oncol 1993; 14: 271-275
8. Char DH, Ljung BM, Miller T et al. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988; 95: 625-630
9. Corboy JR, Garl PJ, Kleinschmidt-DeMasters BK. Human Herpesvirus 8 DNA in CNS lymphomas in patients with and without AIDS. Neurology 1998; 50: 335-340
10. DeAngelis LM, Yahalom J, Heinemann MH et al. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 1990; 40: 80-86
11. DeAngelis LM, Yahalom J, Thaler HAT et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635-643
12. de Smet MD, Stark-Vancs V, Kohler DR et al. Intraocular levels of Methotrexate after intravenous administration. Am J Ophthalmol 1996; 121: 442-444
13. Desablens B, Gardembas M, Haie-Meder C. Primary central nervous system lymphoma: long-term results of the GOELAMS LCP 88 trial with a focus on neurological complications among the 152 patients. Ann Oncol 1999; 10 (Suppl. 3): 14
14. Freeman LN, Schachat AP, Knox DL et al. Clinical features, laboratory investigations and survival in ocular reticulum cell sarcoma. Ophthalmology 1987; 94: 1631-1639
15. Galoin S, Daste G, Apoil PA et al. Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement in B cell lymphoma and leukemia: a novel strategy and its implications. Br J Hematol 1997; 99: 122-130
16. Gill MK, Jampol LM. Variations in the clinical presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 2001; 45: 463-471
17. Glass J, Gruber ML, Cher L et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994; 81: 188-195
18. Henson JW, Yang J, Batchelor T. Intraocular MTX level after high dose intravenous infusion. J Clin Oncol 1999; 17: 1329
19. Herrlinger U, Schabet M, Brugger W et al. for the Neuro-Oncology Working Group (NOA) of the German Cancer Society. NOA03 multicenter trial of single agent high-dose methotrexate for primary CNS lymphoma. Ann Neurol 2002; 51: 247-252
20. Krogh-Jensen M, Johansen P, D'Amore F. Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki 67 proliferation index, p53 and bcl-2 expression. Leuk Lymphoma 1998; 30: 131-142
21. Larocca LM, Capello D, Rinelli A et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consitent with histogenetic derivation from germinal center-related B cells. Blood 1998; 92: 1011-1019
22. Manns A, Hanchard B, Morgan OS et al. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia. J Natl Cancer Inst 1998; 90: 617-622
23. Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9-17
24. O'Brien P, Roos D, Liew K. A phase 2 study of brief single agent iv methotrexate followed by irradiation in primary CNS lymphoma. Ann Oncol 1999; 10 (Suppl. 3): 14
25. Peterson K, Gordon KB, Heinemann MH et al. The clinical spectrum of ocular lymphoma. Cancer 1993; 72: 843-849
26. Reni M, Ferreri AJM, Garancini MP et al. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature. Ann Oncol 1997; 8: 227-234
27. Rhodes CH, Glantz MJ, Glantz L et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996; 77: 543-549
28. Rohrbach JM, Zierhut M. Intraokuläres (okulozerebrales) Non-Hodgkin-Lymphom. Ophthalmologe 2001; 98: 495-507
29. Schultz C, Scott C, Sherman N et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1995; 14: 556-564
30. Shen DF, Zhuang Z, LeHoang P et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 1998; 105: 1664-1669
31. Siegel MJ, Dalton J, Friedman AH et al. Ten year experience with primary ocular "reticulum cell sarcoma" (large cell non-Hodgkin's lymphoma). Br J Ophthalmol 1989; 73: 342-346
32. Slevin ML, Piall EM, Aherne GW et al. Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol 1983: 1: 546-551
33. Smith JR, Rosenbaum JT, Wilson DJ et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002; 109: 1709-1716
34. Taylor GM, Gokhale DA, Crowther D et al. Increased frequency of HLA-DPB*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated. Leukemia 1996; 10: 854-859
35. Ursea R, Heinemann MH, Silverman RH et al. (1997) Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement. Retina 1997; 17: 118-123
36. Velez G, Yuan P, Sung C et al. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 2001; 119: 1518-1524
37. Whitcup SM, de Smet MD, Rubin B et al. Intraocular lymphoma. Clinical and histopathologic diagnosis Ophthalmology 1993; 100: 1399-1406
38. Whitcup SM, Stark-Vancs V, Wittes RE et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997; 115: 1157-1160
39. Wilson DJ, Braziel R, Rosenbaum JT. Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol 1992; 110: 1455-1458
40. Zaman AG, Graham EM, Sanders MD. Anterior visual system involvement in non-Hodgkin's lymphoma. Br J Ophthalmol 1993; 77: 184-187
41. http://www.medizin.fu-berlin.de/haema/pcnsl.htm
42. http://www.uni-tuebingen.de/uni/knk/AG_Weller/index.htm